Please login to the form below

Not currently logged in
Email:
Password:

Merck & Co appoints Frank Clyburn as president, human health

Clyburn joined the company in 2008, most recently serving as chief commercial officer for human health

Merck & Co – known as MSD outside the US and Canada – has appointed Frank Clyburn (pictured above) as president, human health.

In a statement, Merck & Co announced that Clyburn will take on the role effective immediately, and will lead all human health marketing and commercial operations.

He will be responsible for the company’s human health profit and loss (P&L) globally, reporting to Merck’s current chief executive officer Kenneth Frazier.

In January 2019, Clyburn became chief commercial officer for human health at Merck & Co.

Prior to this, he was president of the company’s global oncology business.

Clyburn joined Merck & Co in 2008 and during his time with the company, he has had responsibility for various global pharmaceutical franchises.

“I have tremendous respect for Frank’s strategic and operational excellence, and believe he is the perfect person to lead our ongoing success in human health,” said Robert Davis, executive vice president, global services and chief financial officer of Merck & Co.

“Frank’s leadership in rapidly expanding our oncology footprint and accelerating the growth of that business is unparalleled in our industry, exceeded only by his relentless dedication to helping patients. I look forward to continuing to work with him as we advance Merck’s mission to save and improve lives,” he added.

Article by
Lucy Parsons

19th March 2021

From: Research

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
foxandcat.online

some pressure is helpful but too much of the wrong sort quickly takes its toll. we help creatove agenices manage...

Latest intelligence

What does the future hold for clinical trial recruitment?
The past couple of years have raised several aspects of healthcare in the public’s consciousness – and one of the leading ones has been the role of clinical trials in...
When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...